These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

660 related items for PubMed ID: 11393785

  • 21. Parathyroid-induced angiogenesis is VEGF-dependent.
    Carter WB, Uy K, Ward MD, Hoying JB.
    Surgery; 2000 Sep; 128(3):458-64. PubMed ID: 10965318
    [Abstract] [Full Text] [Related]

  • 22. Receptor activator of NF-kappaB ligand enhances breast cancer-induced osteolytic lesions through upregulation of extracellular matrix metalloproteinase inducer/CD147.
    Rucci N, Millimaggi D, Mari M, Del Fattore A, Bologna M, Teti A, Angelucci A, Dolo V.
    Cancer Res; 2010 Aug 01; 70(15):6150-60. PubMed ID: 20631064
    [Abstract] [Full Text] [Related]

  • 23. Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells.
    Barleon B, Siemeister G, Martiny-Baron G, Weindel K, Herzog C, Marmé D.
    Cancer Res; 1997 Dec 01; 57(23):5421-5. PubMed ID: 9393770
    [Abstract] [Full Text] [Related]

  • 24. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
    Buijs JT, Henriquez NV, van Overveld PG, van der Horst G, Que I, Schwaninger R, Rentsch C, Ten Dijke P, Cleton-Jansen AM, Driouch K, Lidereau R, Bachelier R, Vukicevic S, Clézardin P, Papapoulos SE, Cecchini MG, Löwik CW, van der Pluijm G.
    Cancer Res; 2007 Sep 15; 67(18):8742-51. PubMed ID: 17875715
    [Abstract] [Full Text] [Related]

  • 25. Transforming growth factor-beta in osteolytic breast cancer bone metastases.
    Guise TA, Chirgwin JM.
    Clin Orthop Relat Res; 2003 Oct 15; (415 Suppl):S32-8. PubMed ID: 14600590
    [Abstract] [Full Text] [Related]

  • 26. Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.
    Shibuya M, Seetharam L, Ishii Y, Sawano A, Gotoh N, Matsushime H, Yamaguchi S.
    Princess Takamatsu Symp; 1994 Oct 15; 24():162-70. PubMed ID: 8983073
    [Abstract] [Full Text] [Related]

  • 27. Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice.
    Sasaki A, Boyce BF, Story B, Wright KR, Chapman M, Boyce R, Mundy GR, Yoneda T.
    Cancer Res; 1995 Aug 15; 55(16):3551-7. PubMed ID: 7627963
    [Abstract] [Full Text] [Related]

  • 28. [Inhibitation of tumor angiogenesis, growth and metastasis by blocking VEGF paracrine pathway].
    Wang F, Tian YH, Li L, Chen XF, Hu HH, Li CY, Huang Q.
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Mar 15; 34(2):165-70. PubMed ID: 12006990
    [Abstract] [Full Text] [Related]

  • 29. Gene transfer of a soluble receptor of VEGF inhibits the growth of experimental eyelid malignant melanoma.
    Shiose S, Sakamoto T, Yoshikawa H, Hata Y, Kawano Y, Ishibashi T, Inomata H, Takayama K, Ueno H.
    Invest Ophthalmol Vis Sci; 2000 Aug 15; 41(9):2395-403. PubMed ID: 10937546
    [Abstract] [Full Text] [Related]

  • 30. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
    Abu-Jawdeh GM, Faix JD, Niloff J, Tognazzi K, Manseau E, Dvorak HF, Brown LF.
    Lab Invest; 1996 Jun 15; 74(6):1105-15. PubMed ID: 8667614
    [Abstract] [Full Text] [Related]

  • 31. The parathyroid hormone-related protein (PTHrP) gene: use of downstream TATA promotor and PTHrP 1-139 coding pathways in primary breast cancers vary with the occurrence of bone metastasis.
    Bouizar Z, Spyratos F, De vernejoul MC.
    J Bone Miner Res; 1999 Mar 15; 14(3):406-14. PubMed ID: 10027905
    [Abstract] [Full Text] [Related]

  • 32. cAMP-response-element-binding protein positively regulates breast cancer metastasis and subsequent bone destruction.
    Son J, Lee JH, Kim HN, Ha H, Lee ZH.
    Biochem Biophys Res Commun; 2010 Jul 23; 398(2):309-14. PubMed ID: 20599715
    [Abstract] [Full Text] [Related]

  • 33. Early detection of bone metastases in a murine model using fluorescent human breast cancer cells: application to the use of the bisphosphonate zoledronic acid in the treatment of osteolytic lesions.
    Peyruchaud O, Winding B, Pécheur I, Serre CM, Delmas P, Clézardin P.
    J Bone Miner Res; 2001 Nov 23; 16(11):2027-34. PubMed ID: 11697798
    [Abstract] [Full Text] [Related]

  • 34. Anti-tumor effect in human breast cancer by TAE226, a dual inhibitor for FAK and IGF-IR in vitro and in vivo.
    Kurio N, Shimo T, Fukazawa T, Takaoka M, Okui T, Hassan NM, Honami T, Hatakeyama S, Ikeda M, Naomoto Y, Sasaki A.
    Exp Cell Res; 2011 May 01; 317(8):1134-46. PubMed ID: 21338601
    [Abstract] [Full Text] [Related]

  • 35. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
    Amemiya Y, Yang W, Benatar T, Nofech-Mozes S, Yee A, Kahn H, Holloway C, Seth A.
    Breast Cancer Res Treat; 2011 Apr 01; 126(2):373-84. PubMed ID: 20464481
    [Abstract] [Full Text] [Related]

  • 36. Dual function of ERRα in breast cancer and bone metastasis formation: implication of VEGF and osteoprotegerin.
    Fradet A, Sorel H, Bouazza L, Goehrig D, Dépalle B, Bellahcène A, Castronovo V, Follet H, Descotes F, Aubin JE, Clézardin P, Bonnelye E.
    Cancer Res; 2011 Sep 01; 71(17):5728-38. PubMed ID: 21734015
    [Abstract] [Full Text] [Related]

  • 37. HOXB7: a key factor for tumor-associated angiogenic switch.
    Carè A, Felicetti F, Meccia E, Bottero L, Parenza M, Stoppacciaro A, Peschle C, Colombo MP.
    Cancer Res; 2001 Sep 01; 61(17):6532-9. PubMed ID: 11522651
    [Abstract] [Full Text] [Related]

  • 38. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
    Gabrovska PN, Smith RA, Tiang T, Weinstein SR, Haupt LM, Griffiths LR.
    Gene; 2011 Dec 10; 489(2):63-9. PubMed ID: 21925246
    [Abstract] [Full Text] [Related]

  • 39. Vascular endothelial growth factor gene expression in the human breast cancer cell line MX-1 is controlled by O2 availability in vitro and in vivo.
    Marxsen JH, Schmitt O, Metzen E, Jelkmann W, Hellwig-Bürgel T.
    Ann Anat; 2001 May 10; 183(3):243-9. PubMed ID: 11396794
    [Abstract] [Full Text] [Related]

  • 40. Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs.
    Capulli M, Angelucci A, Driouch K, Garcia T, Clement-Lacroix P, Martella F, Ventura L, Bologna M, Flamini S, Moreschini O, Lidereau R, Ricevuto E, Muraca M, Teti A, Rucci N.
    J Bone Miner Res; 2012 Nov 10; 27(11):2387-98. PubMed ID: 22714395
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.